publicado em 17/01/2013 às 20h03:00
   Dê o seu voto:

Brazil reaches therapeutic outcomes in developed countries leukemia

Consortium shows the capability of conducting clinical trials of high complexity and based on the reality of the Country

font size

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.

Study organized by international consortium between developing and developed countries, showed that through networking and education you can get medical and similar promising results in the treatment and quality of care in cases of onco-hematology, especially acute promyelocytic leukemia ( LPA), disease-targeted research due to their severity, with a high early mortality but good prognosis if detected and treated early.

Published in the journal Blood, the scientific journal of global benchmark in the art of the American Society of Hematology (ASH, its acronym in English), the article included the participation of Brazil, Mexico, Chile, Uruguay, and the United States and Europe and highlights Brazil's performance in the area.

Cooperation showed Brazil's ability to conduct clinical studies of high complexity, based on the reality of the country, obtaining results similar to those described in developed countries. Moreover, it exposes the challenges, weaknesses and difficulties of promoting science in Brazil, in terms of funding and the reality of their public function, among other items, while puts a differentiated level compared to other countries development, says the coordinator of the International Consortium of LPA in Brazil, researcher at the Center for Cellular Therapy Blood Center of Ribeirão Preto (CTC-HRP) and Eduardo Rego hematologist.

Rego, who is also a board member of the Association of Hematology, Hematology and Cell Therapy (ABHH), says that through the initiative of the American Society of Hematology (ASH), was born the first study model for developing countries in the form of consortium of the history of hematology. This model and the way we conduct the study are unpublished. We show that the Internet is also a tool that contributes to advances in medicine.

Seven other Brazilian institutions participating Reference Consortium: Unicamp, Faculty of Medicine, Santa Casa de São Paulo, Hemope Foundation (Pernambuco); Federal Universities of São Paulo, Paraná, Rio Grande do Sul and Minas Gerais. Rounding out the list Mexico, Chile and Uruguay, and institutions of the United States and Europe.


   Palavras-chave:   Leukemia onco-hematology    Acute promyelocytic leukemia    Networking      
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Brazil reaches therapeutic outcomes in developed countries leukemia
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Brazil reaches therapeutic outcomes in developed countries leukemia

Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
leukemia onco-hematology    acute promyelocytic leukemia    networking       
Leave your comment
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story:
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaú
Get the newsletter of the portal  iSaú
Recommend the portal iSaú
News from  iSaú in your blog or website.
Get news on the subject of your interest.
© 2000-2011 Todos os direitos reservados.